Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.
The Hims brand has primed people to view both their everyday health and the natural-aging processes as problems that can be ...
Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...
CNBC's Brandon Gomez joins 'Squawk on the Street' to break down the controversy around Hims & Hers Super Bowl ads.
Hims has a great deal of meme potential, which could benefit the company by effectively acting as free advertising. Read more ...
Telehealth company Hims & Hers is pushing the boundaries of drug compounding and testing the limits of regulators.
Hims & Hers stock price continues to fire on all cylinders this year and is hovering near its highest level on record. It has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results